Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BIOL

Biolase

$2.16

0.04 (1.89%)

13:25
09/21/18
09/21
13:25
09/21/18
13:25
Conference/Events
Biolase to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 27

    Sep

BIOL

Biolase

$2.12

0.05 (2.42%)

04:55
09/21/18
09/21
04:55
09/21/18
04:55
Conference/Events
Biolase to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 27

    Sep

Tuesday
BIOL

Biolase

$2.06

-0.02 (-0.96%)

15:30
09/18/18
09/18
15:30
09/18/18
15:30
Conference/Events
Biolase to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Over a month ago
BIOL

Biolase

$1.21

-0.06 (-4.72%)

08:39
08/08/18
08/08
08:39
08/08/18
08:39
Earnings
Biolase reports Q2 non-GAAP EPS (20c), consensus (20c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

BIOL

Biolase

$1.21

-0.06 (-4.72%)

, DHR

Danaher

$102.28

-0.02 (-0.02%)

08:06
08/08/18
08/08
08:06
08/08/18
08:06
Hot Stocks
Biolase names Todd Norbe as CEO, John Beaver as CFO »

BIOLASE (BIOL) announced…

BIOL

Biolase

$1.21

-0.06 (-4.72%)

DHR

Danaher

$102.28

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

Over a quarter ago
BIOL

Biolase

$1.37

0.03 (2.24%)

08:06
05/30/18
05/30
08:06
05/30/18
08:06
Hot Stocks
Biolase regains Nasdaq compliance »

BIOLASE announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOL

Biolase

$0.34

0.0174 (5.44%)

06:11
05/10/18
05/10
06:11
05/10/18
06:11
Hot Stocks
BIOLASE says stock to being trading on post-reverse stock split basis on May 11 »

BIOLASE announced that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOL

Biolase

$0.36

0.0109 (3.09%)

16:30
05/02/18
05/02
16:30
05/02/18
16:30
Earnings
BIOLASE reports Q1 non-GAAP EPS (4c), consensus (5c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BIOL

Biolase

$0.37

-0.0304 (-7.55%)

08:07
04/11/18
04/11
08:07
04/11/18
08:07
Hot Stocks
BIOLASE commences process to explore strategic alternatives »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOL

Biolase

$0.37

-0.0304 (-7.55%)

08:07
04/11/18
04/11
08:07
04/11/18
08:07
Hot Stocks
BIOLASE names John Beaver as interim CEO, effective immediately »

BIOLASE announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.